Rigel Pharmaceuticals (RIGL) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2026)
Rigel Pharmaceuticals (RIGL) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Rigel Pharmaceuticals |
603.18 Mn |
456.49 Mn |
54.21 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-96.88% |
| Dec 31, 2025 |
865.75% |
| Sep 30, 2025 |
-55.49% |
| Jun 30, 2025 |
420.63% |
| Mar 31, 2025 |
-22.22% |
| Dec 31, 2024 |
15.71% |
| Sep 30, 2024 |
1,266.67% |
| Jun 30, 2024 |
87.23% |
| Mar 31, 2024 |
-1,040.00% |
| Dec 31, 2023 |
115.15% |
| Sep 30, 2023 |
13.16% |
| Jun 30, 2023 |
-375.00% |
| Mar 31, 2023 |
97.41% |
| Dec 31, 2022 |
-2,709.09% |
| Sep 30, 2022 |
-37.50% |
| Jun 30, 2022 |
50.00% |
| Mar 31, 2022 |
-14.29% |
| Dec 31, 2021 |
-16.67% |
| Sep 30, 2021 |
-50.00% |
| Jun 30, 2021 |
-136.36% |
